These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34011880)

  • 1. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin Summary, Number 228.
    Obstet Gynecol; 2021 Jun; 137(6):1131-1133. PubMed ID: 34011880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228.
    Obstet Gynecol; 2021 Jun; 137(6):e100-e115. PubMed ID: 34011888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.
    Laberge PY; Murji A; Vilos GA; Allaire C; Leyland N; Singh SS
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1521-1524. PubMed ID: 31548041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACOG Committee Opinion No. 770 Summary: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):604-605. PubMed ID: 30801469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion Summary, Number 822.
    Obstet Gynecol; 2021 Mar; 137(3):552-553. PubMed ID: 33595248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACOG Committee Opinion No. 770: Uterine Morcellation for Presumed Leiomyomas.
    Obstet Gynecol; 2019 Mar; 133(3):e238-e248. PubMed ID: 30801477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACOG practice bulletin. Surgical alternatives to hysterectomy in the management of leiomyomas. Number 16, May 2000 (replaces educational bulletin number 192, May 1994).
    ACOG Committee on Practice Bulletins-Gynecology.
    Int J Gynaecol Obstet; 2001 Jun; 73(3):285-93. PubMed ID: 11424914
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
    Zurawin RK; Fischer JH; Amir L
    J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Pelvic Pain: ACOG Practice Bulletin Summary, Number 218.
    Obstet Gynecol; 2020 Mar; 135(3):744-746. PubMed ID: 32080045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of leiomyomas in perimenopausal women.
    Ciarmela P; Ciavattini A; Giannubilo SR; Lamanna P; Fiorini R; Tranquilli AL; Christman GM; Castellucci M
    Maturitas; 2014 Jul; 78(3):168-73. PubMed ID: 24835002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic management of uterine fibroid tumors: updated French guidelines.
    Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACOG practice bulletin. Alternatives to hysterectomy in the management of leiomyomas.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):387-400. PubMed ID: 18669742
    [No Abstract]   [Full Text] [Related]  

  • 15. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
    Babashov V; Palimaka S; Blackhouse G; O'Reilly D
    Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACR Appropriateness Criteria
    ; Knuttinen MG; Stark G; Hohenwalter EJ; Bradley LD; Braun AR; Gipson MG; Kim CY; Pinchot JW; Scheidt MJ; Sella DM; Weiss CR; Lorenz JM
    J Am Coll Radiol; 2018 May; 15(5S):S160-S170. PubMed ID: 29724419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACR Appropriateness Criteria® on treatment of uterine leiomyomas.
    Burke CT; Funaki BS; Ray CE; Kinney TB; Kostelic JK; Loesberg A; Lorenz JM; Millward SF; Nemcek AA; Owens CA; Shaw H; Silberzweig JE; Vatakencherry G
    J Am Coll Radiol; 2011 Apr; 8(4):228-34. PubMed ID: 21458760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic Fibroid Management: Systematic Review of the Literature.
    Havryliuk Y; Setton R; Carlow JJ; Shaktman BD
    JSLS; 2017; 21(3):. PubMed ID: 28951653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine artery embolization as a treatment option for uterine myomas.
    Marshburn PB; Matthews ML; Hurst BS
    Obstet Gynecol Clin North Am; 2006 Mar; 33(1):125-44. PubMed ID: 16504811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.